Medicare opens more coverage to cancer drugs

In the New York Times today, they looked at the new coverage of drugs for cancer that have not been approved by the FDA. Doctors see the use of these drugs as a way that patients can receive more up-to-date care. It also enhances the understanding of which treatments work for cancer. For the full article, read here.